Stem cell therapies for pulmonary fibrosis: emerging hope through ongoing challenges
摘要
Stem cell therapy represents an emerging intervention for pulmonary fibrosis (PF), a severe lung disease lacking effective treatments. We conducted a systematic retrospective review of stem cell clinical trials for PF registered up to the end of 2024, utilizing the Trialtrove database alongside other registries.